
Bausch + Lomb Announces Second-Quarter 2025 Results
Bausch + Lomb Announces Second-Quarter 2025 Results

Bausch + Lomb Announces Second-Quarter 2025 Results
Perimeter closes $2.22M second tranche of offering
ME Therapeutics investor Dhanji acquires shares
Onco-Innovations Announces Private Placement
Briacell files patent for TILsRx cancer therapy system
Bausch + Lomb's Lumify phase 3 data published
Microbix Biosystems rolls out Quantdx product line
Bausch Health to acquire Durect
Ventripoint receives purchase order from Lishman
Bausch Health unit to redeem $602M of notes Aug. 28
Netramark signs contract with AlgoTherapeutix
Principal Tech to complete $624K second round financing
Theralase Technologies closes $672,727 financing
Bionxt closes first tranche of debenture unit financing
Pangenomic talks up AI health system NaraCare.AI